Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly)

PFE 27.22

+2.8%

Feb 6 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Anthony Wong who wrote (29)	5/26/1998 4:25:00 PM
From: Anthony Wong	of 1722

Centocor Inc reiterated buy NEW YORK, May 26 (Reuters) - Lehman Brothers on Tuesday reiterated its buy rating on Centocor Inc.'s stock, saying the shares' weakness last week presents a buying opportunity. The stock was off last Friday amid fear a U.S. Food and Drug Administration panel would not recommend approval of the company's Avakine drug. Lehman, however, said it believes there is a high probability the panel will recommend approval of the drug, used to treat patients with Crohn's disease. The drug will go before an FDA panel on Thursday. Centocor shares stood at 38-15/16, up 1-11/16. biz.yahoo.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next